Neuroendovascular Non-coils Market to grow by USD 329.15 million from 2023 to 2028- Technavio
09 Nov 2023
NEW YORK, Nov. 9, 2023 /PRNewswire/ -- The
neuroendovascular non-coils market is expected to grow by
USD 329.15 million from 2023 to 2028. In addition, the momentum of the market will progress at a
CAGR of 4.29% during the forecast period, according to Technavio Research. The market has segmented by product type (Neuroendovascular stents, Access devices, Flow diversion devices, and Others), end-user (Hospitals, Ambulatory surgical centers (ASCs), Stroke centers, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW)).
North America is estimated to account for
39% of the global market growth during the forecast period. The North American market is experiencing substantial growth, primarily due to factors like continuous advancements in technology, frequent product launches, and increased investments in startup companies aimed at developing innovative and advanced medical devices.
This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read PDF Free Sample Report
Continue Reading
Preview
Source: PRNewswire
Technavio has announced its latest market research report titled Global Neuroendovascular Non-coils Market 2024-2028
Company Profile:
Cook Group Inc., Johnson and Johnson, Kaneka Corp., Medtronic Plc, Penumbra Inc., Rapid Medical Ltd., Shape Memory Medical Inc., Stryker Corp., Terumo Corp., Wallby Medical LLC, and BALT Group
Cook Group Inc: The company offers neuroendovascular non-coils such as Optima or OptiMAX coil systems intended for use in the peripheral and neurovasculature to endovascularly obstruct or occlude blood flow.
To gain access to more vendor profiles available with Technavio, buy the report!
Neuroendovascular Non-coils Market: Segmentation Analysis
The
Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Free Sample Report
"Besides analyzing the current market scenario, our report examines historic data from 2018 to 2022"- Technavio
Neuroendovascular Non-coils Market: Driver & Trend:
The increasing incidence of intracranial aneurysms is notably driving the market growth. The increasing prevalence of intracranial aneurysms, alternatively referred to as cerebral aneurysms or brain aneurysms, is a prominent catalyst for the expansion of the global neuroendovascular non-coils market. This surge in cases is driving the need for more efficient and cutting-edge treatment alternatives.
The growing awareness and education about intracranial aneurysms is an emerging trend shaping the market growth.
Strategic alliances among market vendors are a key trend in the neuroendovascular non-coils market. Identify key trends, drivers, and challenges in the market. Download a sample to gain access to this information.
What are the key data covered in this neuroendovascular non-coils market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the neuroendovascular non-coils market between 2023 and 2028.
Precise estimation of the neuroendovascular non-coils market size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the neuroendovascular non-coils market across North America, Europe, Asia, and ROW
A thorough analysis of the market's competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of neuroendovascular non-coils market vendors.
Related Reports:
The
embolization coil market is estimated to grow at a CAGR of 5.69% between 2022 and 2027. The size of the market is forecast to increase by USD 481.9 million.
The
aneurysm coiling and embolization devices market share is expected to increase by USD 1.87 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.06%.
ToC:
Executive Summary
Market Landscape
Market Sizing
Historic Market Sizes
Five Forces Analysis
Market Segmentation by Product Type
Market Segmentation by End-user
Market Segmentation by Geography
Customer Landscape
Geographic Landscape
Drivers, Challenges, & Trends
Company Landscape
Company Analysis
Appendix
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.